Kaygee Investments Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
IPCALAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The promoter group of Ipca Laboratories, led by Kaygee Investments Pvt. Ltd. along with 16 other promoter entities and persons acting in concert, has filed an annual declaration under SEBI's Takeover Regulations. They confirm that no encumbrance (such as pledge, lien, or charge) was created, directly or indirectly, on their equity shares in Ipca Laboratories during the financial year ended 31 March 2025. The filing was made to both BSE and NSE on 8 April 2025 as a routine annual compliance requirement.
This is a routine positive compliance disclosure. It reassures investors that the promoter family has not pledged or encumbered their stake during the year, indicating no funding stress or leverage being raised against their shareholding.